REGENXBIO Inc. Earnings Per Share Diluted

Quick Answer

REGENXBIO Inc. reported Earnings Per Share Diluted of $3.76 (loss) per share for the year ending 2025.

  • REGENXBIO Inc. showed an increase of +18.1% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from REGENXBIO Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
  • XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2017: $0.82 (loss) per share | Q2 2017: $0.47 (loss) per share | Q3 2017: $0.67 (loss) per share | Q4 2017: $0.51 (loss) per share | Q1 2018: $3.04 per share | Q2 2018: $0.30 per share | Q3 2018: $0.56 (loss) per share | Q4 2018: $0.11 per share | Q1 2019: $0.89 (loss) per share | Q2 2019: $0.04 (loss) per share | Q3 2019: $0.94 (loss) per share | Q4 2019: $0.72 (loss) per share | Q1 2020: $1.08 (loss) per share | Q2 2020: $0.91 (loss) per share | Q3 2020: $0.23 per share | Q4 2020: $1.24 (loss) per share | Q2 2021: $1.36 (loss) per share | Q3 2021: $1.37 (loss) per share | Q1 2022: $1.79 (loss) per share | Q2 2022: $1.58 (loss) per share | Q3 2022: $1.75 (loss) per share | Q1 2023: $1.53 (loss) per share | Q2 2023: $1.66 (loss) per share | Q3 2023: $1.41 (loss) per share | Q1 2024: $1.38 (loss) per share | Q2 2024: $1.05 (loss) per share | Q3 2024: $1.17 (loss) per share | Q1 2025: $0.12 per share | Q2 2025: $1.38 (loss) per share | Q3 2025: $1.20 (loss) per share.
  • Over the full 10 years of available data (2016 to 2025), REGENXBIO Inc.'s Earnings Per Share Diluted has declined by 58.0%.
  • Historical annual values: Fiscal year 2025: $3.76 (loss) per share | Fiscal year 2024: $4.59 (loss) per share | Fiscal year 2023: $6.02 (loss) per share | Fiscal year 2022: $6.50 (loss) per share | Fiscal year 2021: $2.91 per share | Fiscal year 2020: $2.98 (loss) per share | Fiscal year 2019: $2.58 (loss) per share | Fiscal year 2018: $2.73 per share | Fiscal year 2017: $2.45 (loss) per share | Fiscal year 2016: $2.38 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: